0

Journal Articles

in Neurology
 461-480 of 586 Articles
Original Investigation |  FREE
Sanjay Dixit, MD; Martha Castle, RN; Raja P. Velu, PhD; et al.
Arch Intern Med. 2000;160(20):3153-3158. doi:10.1001/archinte.160.20.3153.

Original Investigation |  FREE
Victor G. Valcour, MD; Kamal H. Masaki, MD; J. David Curb, MD, MPH; et al.
Arch Intern Med. 2000;160(19):2964-2968. doi:10.1001/archinte.160.19.2964.

Original Investigation |  FREE
Larry B. Goldstein, MD; John Bian, MS; Gregory P. Samsa, PhD; et al.
Arch Intern Med. 2000;160(19):2941-2946. doi:10.1001/archinte.160.19.2941.

Original Investigation |  FREE
David R. Gifford, MD, MPH; Robert G. Holloway, MD, MPH; Barbara G. Vickrey, MD, MPH
Arch Intern Med. 2000;160(18):2855-2862. doi:10.1001/archinte.160.18.2855.

Original Investigation |  FREE
Tiejian Wu, MD, PhD; Maurizio Trevisan, MD, MS; Robert J. Genco, DDS, PhD; et al.
Arch Intern Med. 2000;160(18):2749-2755. doi:10.1001/archinte.160.18.2749.

Original Investigation |  FREE
François P. Sarasin, MD; Jean-Michel Gaspoz, MD, MSc; Henri Bounameaux, MD
Arch Intern Med. 2000;160(18):2773-2778. doi:10.1001/archinte.160.18.2773.

Review Article |  FREE
Gerald W. Smetana, MD
Arch Intern Med. 2000;160(18):2729-2737. doi:10.1001/archinte.160.18.2729.

Editor's Correspondence | 
Henry Zeimer, MBBS
Arch Intern Med. 2000;160(18):2866. doi:.

Editor's Correspondence | 
Carlos Perez, MD; Eduardo Loza, MD; Tomas Tinture, MD
Arch Intern Med. 2000;160(17):2677. doi:.

Editor's Correspondence | 
Andrew McD Johnston, MRCP
Arch Intern Med. 2000;160(17):2679-2680. doi:.

Editor's Correspondence | 
Philip A. Mackowiak, MD; Karen I. Plaisance, PharmD
Arch Intern Med. 2000;160(17):2679-2680. doi:.

Editor's Correspondence | 
Syed Wamique Yusuf, MRCP
Arch Intern Med. 2000;160(17):2682-2683. doi:.

Editor's Correspondence | 
Sundaram V. Ramanan, MD
Arch Intern Med. 2000;160(16):2546. doi:.

Review Article |  FREE
Not Available Habib-ur-Rehman, MRCP
Arch Intern Med. 2000;160(16):2438-2444. doi:10.1001/archinte.160.16.2438.

Original Investigation |  FREE
Edward O. Bixler, PhD; Alexandros N. Vgontzas, MD; Hung-Mo Lin, PhD; et al.
Arch Intern Med. 2000;160(15):2289-2295. doi:10.1001/archinte.160.15.2289.

Original Investigation |  FREE
Robert P. Blankfield, MD, MS; David W. Hudgel, MD; Amy Artim Tapolyai, MBA; et al.
Arch Intern Med. 2000;160(15):2357-2362. doi:10.1001/archinte.160.15.2357.

Review Article |  FREE
Michael Bottorff, PharmD; Philip Hansten, PharmD
Arch Intern Med. 2000;160(15):2273-2280. doi:10.1001/archinte.160.15.2273.

Original Investigation |  FREE
Barbara Phillips, MD, MSPH, FCCP; Terry Young, PhD; Laurel Finn, MS; et al.
Arch Intern Med. 2000;160(14):2137-2141. doi:10.1001/archinte.160.14.2137.

Original Investigation |  FREE
Denis G. Wahl, MD, PhD; Henri Bounameaux, MD; Philippe de Moerloose, MD; et al.
Arch Intern Med. 2000;160(13):2042-2048. doi:10.1001/archinte.160.13.2042.

Editor's Correspondence | 
Jaakko Antonen, MD, PhD; Janne Hulkkonen, MD; Amos Pasternack, MD, PhD; et al.
Arch Intern Med. 2000;160(13):2061-2067. doi:.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Editorial  | 
Real-world Experience in the Midst of an Exserohilum Meningitis Outbreak
George R. Thompson, MD; Dimitrios P. Kontoyiannis, MD; Thomas F. Patterson, MD
JAMA
Original Contribution  | 
Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
Jeffrey L. Saver, MD; Gregg C. Fonarow, MD; Eric E. Smith, MD, MPH; et al.
JAMA
News From the Centers for Disease Control and Prevention  | 
Persistent Obstacles Mar Progress in Eradicating Polio

JAMA Neurology
Observation  | 
Successful Treatment of Anti-Caspr2 Syndrome by Interleukin 6 Receptor Blockade Through Tocilizumab
Christos Krogias, MD; Robert Hoepner, MD; Andre Müller, MD; et al.